美好医疗
(301363)
| 流通市值：127.26亿 | | | 总市值：193.99亿 |
| 流通股本：3.73亿 | | | 总股本：5.69亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 403,077,520.81 | 1,625,486,540.42 | 1,194,474,058.15 | 732,816,682.76 |
| 营业收入 | 403,077,520.81 | 1,625,486,540.42 | 1,194,474,058.15 | 732,816,682.76 |
| 二、营业总成本 | 337,442,473.35 | 1,273,131,275.66 | 948,450,698.88 | 599,878,465.56 |
| 营业成本 | 236,550,234.13 | 973,791,008.85 | 724,526,977.03 | 457,872,335.92 |
| 税金及附加 | 3,859,666.5 | 17,184,517.2 | 11,838,654.51 | 7,669,951.22 |
| 销售费用 | 11,686,607.75 | 47,365,924.01 | 38,453,680.08 | 24,710,455.41 |
| 管理费用 | 36,842,735.27 | 123,595,016.57 | 96,268,045.72 | 62,364,370.52 |
| 研发费用 | 36,245,285.95 | 133,823,843.76 | 104,754,372.05 | 69,195,515.56 |
| 财务费用 | 12,257,943.75 | -22,629,034.73 | -27,391,030.51 | -21,934,163.07 |
| 其中:利息费用 | 162,900 | 958,885.78 | 38,575.78 | 37,985.51 |
| 其中:利息收入 | 12,497,087.52 | 47,517,801.8 | 34,578,508.31 | 21,227,569.51 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,394,476.99 | -2,706,956.1 | -328,773.89 | -407,103.51 |
| 加:投资收益 | -152,733.73 | 6,611,789.25 | 4,903,105.13 | 3,952,281.16 |
| 资产处置收益 | -9,674.06 | 602,435.05 | 52,229.87 | 28,368.05 |
| 资产减值损失(新) | -5,421,674.22 | -38,981,197.26 | -13,437,938.16 | -9,252,079.44 |
| 信用减值损失(新) | 921,159.8 | -1,681,184.15 | -3,943,062.44 | -1,925,030.34 |
| 其他收益 | 1,913,575.99 | 8,997,169.98 | 4,486,382.49 | 2,740,712.25 |
| 四、营业利润 | 65,280,178.23 | 325,197,321.53 | 237,755,302.27 | 128,075,365.37 |
| 加:营业外收入 | 21,534.5 | 152,003.19 | 130,040.39 | 114,338.76 |
| 减:营业外支出 | 2.62 | 652,917.11 | 86,396.11 | 78,298.81 |
| 五、利润总额 | 65,301,710.11 | 324,696,407.61 | 237,798,946.55 | 128,111,405.32 |
| 减:所得税费用 | 8,618,109 | 41,615,435.71 | 29,596,615.39 | 13,809,262.87 |
| 六、净利润 | 56,683,601.11 | 283,080,971.9 | 208,202,331.16 | 114,302,142.45 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 56,683,601.11 | 283,080,971.9 | 208,202,331.16 | 114,302,142.45 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 56,683,601.11 | 283,080,971.9 | 208,202,331.16 | 114,302,142.45 |
| 扣除非经常损益后的净利润 | 54,345,840.37 | 277,490,686.6 | 203,344,046.58 | 110,637,199.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.1 | 0.5 | 0.37 | 0.2 |
| (二)稀释每股收益 | 0.1 | 0.5 | 0.37 | 0.2 |
| 八、其他综合收益 | -11,024,063.8 | 42,384,985.1 | 21,867,006.73 | 25,921,615.41 |
| 归属于母公司股东的其他综合收益 | -11,024,063.8 | 42,384,985.1 | 21,867,006.73 | 25,921,615.41 |
| 九、综合收益总额 | 45,659,537.31 | 325,465,957 | 230,069,337.89 | 140,223,757.86 |
| 归属于母公司股东的综合收益总额 | 45,659,537.31 | 325,465,957 | 230,069,337.89 | 140,223,757.86 |
| 公告日期 | 2026-04-21 | 2026-04-21 | 2025-10-22 | 2025-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |